Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial - Concepedia

Concepedia

Publication | Open Access

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial

DOI Full Paper Access

49

Citations

22

References

2014

Year

Jonas Eriksson, Johan Karlsson, Johan Bratt, Ingemar F. Petersson, Ronald van Vollenhoven, Sofia Ernestam, Pierre Geborek, Martin Neovius

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1